SR

Sridhar Reddy Gangapuram

Active Director Director DIN 03092149
DIN 03092149 First appointment Jun 2010 Primary industry Business Outsourcing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Sridhar Reddy Gangapuram

Data last updated:

Sridhar Reddy Gangapuram is a Director at Vision Pharma Chem (India) Private Limited (since 2010). The company operates in Business Outsourcing.

DIN 03092149
Primary Designation Director
Industry Business Outsourcing
First Appointment 16 Jun 2010
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jun 20102010Active

Directorship timeline

Open interactive timeline →
Vision Pharma Chem (India) Private Limited
Premium access

Shareholding and investment profile for Sridhar Reddy Gangapuram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridhar Reddy Gangapuram

Sridhar Reddy Gangapuram currently holds 1 directorship: Vision Pharma Chem (India) Private Limited (Director, since 16 Jun 2010).

Sridhar Reddy Gangapuram was first appointed on 16 Jun 2010 as Director at Vision Pharma Chem (India) Private Limited.

The current boards of Sridhar Reddy Gangapuram's companies include Jitendar Reddy Kuchur (Vision Pharma Chem (India) Private Limited), Laxmikanth Reddy Theelatee (Vision Pharma Chem (India) Private Limited), Srinivas Reddy Kuchuru (Vision Pharma Chem (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available